David R. Staskin

Director/Miembro de la Junta en Inpellis, Inc. .

Consumer Services

Health Technology

Perfil

David R.
Staskin is currently the Secretary, Director & Chief Strategy Officer at Inpellis, Inc. He completed his undergraduate degree at Cornell University and his doctorate at Drexel University College of Medicine.

Cargos activos de David R. Staskin

Empresas	Cargo	Inicio
Inpellis, Inc. Inpellis, Inc. Pharmaceuticals: MajorHealth Technology Inpellis, Inc. operates as a specialty pharmaceutical company that focuses on developing and commercializing transdermal prescription therapeutics for treating acute and chronic pain resulting from musculoskeletal disorders and peripheral neuropathy. Its products include transdermal ibuprofen for moderate to severe osteoarthritis and transdermal benfotiamine for painful diabetic neuropathy. The company was founded in 2012 and is headquartered in Haddonfield, NJ.	Director/Miembro de la Junta	01/01/2015

Todos los cargos activos de David R. Staskin

Formación de David R. Staskin.

Cornell University	Undergraduate Degree
Drexel University College of Medicine	Doctorate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de David R. Staskin.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	1
Inpellis, Inc. Inpellis, Inc. Pharmaceuticals: MajorHealth Technology Inpellis, Inc. operates as a specialty pharmaceutical company that focuses on developing and commercializing transdermal prescription therapeutics for treating acute and chronic pain resulting from musculoskeletal disorders and peripheral neuropathy. Its products include transdermal ibuprofen for moderate to severe osteoarthritis and transdermal benfotiamine for painful diabetic neuropathy. The company was founded in 2012 and is headquartered in Haddonfield, NJ.	Health Technology